PharmaVoice 100: Page 2

  • Cancer care visionaries, PharmaVoice 100
    Image attribution tooltip

    Photo illustration: Industry Dive; Getty Images

    Image attribution tooltip
    PharmaVoice 100

    PharmaVoice 100s: Cancer care visionaries

    Leaders shaping the future of oncology and cancer care through grit and determination in the face of one of healthcare’s greatest challenges.

    By • Oct. 2, 2023
  • PharmaVoice 100 trailblazers
    Image attribution tooltip

    Photo illustration: Industry Dive; Getty Images

    Image attribution tooltip

    The PharmaVoice 100: Trailblazers

    Leaders who are going where no biopharma executive has gone before and changing the industry along the way.

    By • Sept. 29, 2023
  • Silhouette of people in business attire in front of a wall of windows
    Image attribution tooltip

    Photo illustration: Industry Dive; Getty Images

    Image attribution tooltip
    PharmaVoice 100

    PharmaVoice 100s: Standout execs

    Leaders who’ve created unique strategies for thriving amid the heavy headwinds facing the industry.

    By • Sept. 25, 2023
  • PharmaVoice 100 header
    Image attribution tooltip

    Illustration: Deena So Oteh for Industry Dive

    Image attribution tooltip

    The 2023 PharmaVoice 100

    This year’s honorees are influential and devoted leaders lifting the pillars of the industry to new heights.

    By • Sept. 19, 2023
  • leaders hands
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    Catching up with 2022 PharmaVoice 100 honorees

    Tapping into our growing community for expertise and inspiration.

    By • Sept. 13, 2023
  • leadership
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    PharmaVoice 100

    The PharmaVoice 100 — Who makes the cut

    What we’re looking for in each new class of honorees.

    By • March 15, 2023
  • silhouette people
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    PharmaVoice 100 honorees: Where are they now?

    How some of our past PharmaVoice 100 honorees are transforming the life sciences industry in new roles. 

    By , Karissa Waddick • March 3, 2023
  • lightbulb breaking
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Opinion

    Healthcare tech’s biggest busts

    The metaverse, blockchain, DCTs and more — here are some of the most recent fails in healthcare tech.

    By • Dec. 2, 2022
  • pills
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip

    10 of our most popular articles in 2022

    Methadone, rock ‘n’ roll, clinical trial overhauls — here’s a look at our most-read stories of the year.

    By • Nov. 30, 2022
  • Glen de Vries blue origin
    Image attribution tooltip
    Permission granted by Medidata
    Image attribution tooltip
    Q&A

    The legacy of Glen de Vries: Our last interview with the pioneering entrepreneur

    Recorded just weeks before his passing, our sit-down interview with the legendary medical sciences entrepreneur showcased his passion for pushing the industry toward its next frontier.

    By • Nov. 11, 2022
  • brand
    Image attribution tooltip
    Stock via Getty Images
    Image attribution tooltip
    Opinion

    What’s your leadership brand?

    Pharma industry leaders share their brand personas.

    By • Oct. 14, 2022
  • Header image for Red Jacket Awards
    Image attribution tooltip
    Shaun Lucas/PharmaVoice
    Image attribution tooltip

    The 2022 Red Jacket honorees

    Our annual PharmaVoice 100 “hall of fame” winners raise the bar on transformative leadership in life sciences.

    Sept. 15, 2022
  • A portrait of Jim Lang framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Jim Lang
    Image attribution tooltip
    Profile // Red Jacket honorees 2022

    Red Jacket: Jim Lang

    The CEO of Eversana has made his mark on the life sciences by disrupting the status quo for commercialization — and he’s got more industry-shifting changes in the works.

    By PharmaVoice staff • Sept. 15, 2022
  • Header of Peyton Howell with PV100 logo
    Image attribution tooltip
    Permission granted by Peyton Howell
    Image attribution tooltip
    Profile // Red Jacket honorees 2022

    Red Jacket: Peyton Howell

    The chief operating and growth officer of Parexel has sold her market access company and created award-winning DE&I programs, but it’s her role as “connector” that she takes the greatest pride in.

    By PharmaVoice staff • Sept. 15, 2022
  • Quita Highsmith header
    Image attribution tooltip
    Permission granted by Quita Highsmith
    Image attribution tooltip
    Profile

    Red Jacket: Quita Highsmith

    The VP and chief diversity officer of Genentech is driving enterprise-wide strategies to influence how the biotech giant approaches DE&I — from clinical trials to career advancement.

    By PharmaVoice staff • Sept. 15, 2022
  • Fabio Gratton header with PV100 logo
    Image attribution tooltip
    Permission granted by Fabio Gratton
    Image attribution tooltip
    Profile // Red Jacket honorees 2022

    Red Jacket: Fabio Gratton

    The serial entrepreneur has relied on his gift for storytelling, creativity and a bit of “magic” as he’s launched one successful niche tech company after another.

    By PharmaVoice staff • Sept. 15, 2022
  • Udit Batra header with PV100 logo
    Image attribution tooltip
    Permission granted by Udit Batra
    Image attribution tooltip
    Profile // Red Jacket honorees 2022

    Red Jacket: Udit Batra

    A combination of logic and love — that’s how the CEO of Waters Corp. leads and how he inspires those around him to “solve the problems that matter.”

    By PharmaVoice staff • Sept. 15, 2022
  • A portrait of Carol Lynch framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Carol Lynch
    Image attribution tooltip
    Profile // PharmaVoice 100

    Legacy Leaders: Carol Lynch

    The chief business officer for Sandoz combines a shrewd business sense with a generous approach to leadership.

    By Alexandra Pecci • Sept. 6, 2022
  • A portrait of Charlene Stern framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Charlene Stern
    Image attribution tooltip
    Profile // PharmaVoice 100

    Disrupters: Charlene Stern

    How the chief lawyer of Editas Medicine is using a multi-lens approach to bolster the development of game-changing genomic medicines.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Chris Round framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Chris Round
    Image attribution tooltip
    Profile // PharmaVoice 100

    Legacy Leaders: Chris Round

    The president of EMD Serono, the U.S. and Canadian healthcare business unit of Merck KGaA, Darmstadt, Germany, has the company firing on all cylinders for near- and long-term growth.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Dr. Cristian Massacesi framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Cristian Massacesi
    Image attribution tooltip
    Profile // PharmaVoice 100

    Innovators: Dr. Cristian Massacesi

    With the goal of redefining how medicines are made, the CMO and oncology CDO is transforming AstraZeneca’s oncology development.

    By • Sept. 6, 2022
  • A portrait of David Katz framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by David Katz
    Image attribution tooltip
    Profile // PharmaVoice 100

    Entrepreneurs: David Katz

    As the founder and chief scientific officer of Sparrow Pharmaceuticals, David Katz is breathing new life into drugs that have previously been shelved.

    By • Sept. 6, 2022
  • A portrait of Dawn Berry framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dawn Berry
    Image attribution tooltip
    Profile // PharmaVoice 100

    Entrepreneurs: Dawn Barry

    The co-founder and president of LunaPBC is seeking to eliminate the middlemen in drug development by connecting patients — and their real-world data — directly with researchers.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Dominique Demolle framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dominique Demolle
    Image attribution tooltip
    Profile // PharmaVoice 100

    Tech Wizards: Dominique Demolle

    How the CEO of Cognivia is revolutionizing drug development with psychonomics.

    By PharmaVoice staff • Sept. 6, 2022
  • A portrait of Dr. Judith Klimovsky framed with a banner icon that reads "PV 100"
    Image attribution tooltip
    Permission granted by Dr. Judith Klimovsky
    Image attribution tooltip
    Profile // PharmaVoice 100

    Innovators: Dr. Judith Klimovsky

    The executive vice president and chief business officer of Genmab is using decades of experience in oncology R&D to fuel advances in antibody-drug conjugates. 

    By • Sept. 6, 2022